Cultures of chick-embryo hepatocytes were used to study the mechanism by which 3,4,3',4'-tetrachlorobiphenyl and 2,4,5,3',4'-pentabromobiphenyl cause accumulation of uroporphyrin. In a previous paper, an isoenzyme of cytochrome P-450 induced by 3-methylcholanthrene had been implicated in this process [Sinclair, Bement, Bonkovsky & Sinclair (1984) Biochem. J. 222, 737-748]. Cells treated with 3,4,3',4'-tetrachlorobiphenyl and 5-aminolaevulinate accumulated uroporphyrin and heptacarboxyporphyrin, whereas similarly treated cells accumulated protoporphyrin immediately after piperonyl butoxide was added. Piperonyl butoxide also restored haem synthesis as detected by (i) incorporation of radioactive 5-aminolaevulinate into haem, and (ii) decrease in drug-induced 5-aminolaevulinate synthase activity. The restoration of synthesis of protoporphyrin and haem by piperonyl butoxide was not affected by addition of cycloheximide, indicating recovery was probably not due to protein synthesis de novo. Piperonyl butoxide also reversed uroporphyrin accumulation caused by 3,4,5,3',4',5'-hexachlorobiphenyl, mixtures of other halogenated biphenyls, lindane, parathion, nifedipine and verapamil. The effect of piperonyl butoxide was probably not due to inhibition ofmetabolism ofthese compounds, since the hexachlorobiphenyl was scarcely metabolized. Other methylenedioxyphenyl compounds, as well as ellipticine and acetylaminofluorene, also reversed the uroporphyrin accumulation caused by 3,4,3',4'-tetrachlorobiphenyl. SKF-525A (2-dimethylaminoethyl-2,2-diphenyl valerate) did not reverse the uroporphyrin accumulation caused by the halogenated biphenyls, but did reverse that caused by phenobarbital and propylisopropylacetamide. We conclude that the mechanism of the uroporphyrin accumulation cannot be due to covalent binding of activated metabolites of halogenated compounds to uroporphyrinogen decarboxylase.
INTRODUCTION
A human disease, porphyria cutanea tarda, is associated with hepatic accumulation of the oxidized porphyrinogens, URO and heptacarboxyporphyrin and with decreased activity of uroporphyrinogen decarboxylase in the liver [for reviews, see Bonkovsky (1982) and Kappas et al. (1983) ]. Activity of this enzyme is also decreased in liver homogenates from animals treated with hexachlorobenzene (Elder et al., 1976) , TCDD (Jones & Sweeney, 1980) or with some polybrominated biphenyls (Voorman et al., 1983) , and this decrease is associated with hepatic accumulation of URO and heptacarboxylporphyrin. Immunological studies indicate that, in treated animals accumulating these porphyrins, the concentration of immunoreactive enzyme is equivalent to that in controls (Elder & Sheppard, 1982) , suggesting that decreased enzyme activity is due to inactivation rather than a decrease in the amount of the enzyme.
A number of halogenated cyclic compounds cause URO accumulation when added to cultures of chickembryo hepatocytes [see review by Marks (1985) ]. Recently, we showed that URO accumulation by intact cells caused by the halogenated biphenyls TCB and PBB is dependent on the induction of an isoenzyme of cytochrome P-450 that is induced by these compounds or by MC (Sinclair et al., 1984a) . We also reported that prior or simultaneous addition of the inhibitors of this P-450 isoenzyme, piperonyl butoxide or ellipticine, prevented URO accumulation caused by the halogenated compounds (Sinclair et al., 1984a) . From these and similar experiments by others using chick liver culture (de Verneuil et al., 1983a; Swain et al., 1983; Debets et al., 1980) or intact animals (Debets et al., 198 la; Wainstock de Calmanovici et al., 1984) it has been suggested that URO accumulation involves metabolism of the halogenated compounds by the P-450 isoenzyme to reactive intermediates which bind covalently to and inhibit uroporphyrinogen decarboxylase. As yet, there is no direct evidence to support this hypothesis.
In the present paper we show that URO accumulation caused by a number of compounds (including TCB and PBB) in cultures of intact chick hepatocytes was rapidly reversed by piperonyl butoxide and other inhibitors of cytochrome P450. This reversal of URO accumulation was detected primarily by change in the pattern of Vol. 237
Abbreviations used: ALA, 5-aminolaevulinic acid; DMSO, dimethyl sulphoxide; HCB, 3, 4, 5, 3', 4', MC, PBB, 2, 4, 5, 3', 4 '-pentabromobiphenyl; PROTO, protoporphyrin; SKF-525A, 2-dimethylaminoethyl-2,2-diphenyl valerate; TCB, 3,4,3',4'-tetrachlorobiphenyl; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; URO, uroporphyrin; PIA, 2-propyl-2-isopropylacetamide. accumulation ofporphyrins, from URO to PROTO, after addition of ALA. In addition, the synthesis ofhaem from ALA was restored to control levels, and feedback repression by intracellular haem of induced ALA synthase was restored.
Our results are incompatible with current mechanistic proposals for URO accumulation that invoke irreversible inhibition of uroporphyrinogen decarboxylase by halogenated hydrocarbons due to covalent binding of metabolites to the enzyme. The implications of these studies for development of the URO accumulation in animals and humans caused by halogenated hydrocarbons are discussed.
Part of this work has appeared in abstract form (Sinclair et al., 1984b) .
MATERIALS AND METHODS Materials
Sources of most of the chemicals were given previously (Sinclair et al., 1984a) . Aroclor-1254 and parathion were from Ultra-Science, Hope, RI, U.S.A. Firemaster and 3, 4, 5, 3', 4', Sinclair & Granick (1977 Primary cultures from livers of 16-day White Leghorn chicken embryos were prepared and maintained in Williams E medium as described previously (Sinclair et al., 1982) . Cells were cultured in 3.5 cm-diameter plastic dishes unless otherwise indicated. Dishes contained 0.5-0.6 mg of protein per 3.5 cm dish or 1.5-1.7 mg of protein per 6 cm dish. Chemicals were added during the second day of culture after cells had been rinsed twice with Williams E medium containing dexamethasone and 3,3',5-tri-iodothyronine, but not insulin. Compounds of poor water solubility were added to cultures in DMSO (not exceeding 4 /1l/ml). In later experiments, we added piperonyl butoxide in 50% (v/v) (11:14, v/v) , pH 3.5; solvent B, 100% methanol; linear gradient, 30-100% B over 12 min, at a flow rate of 1.5 ml/min (Ford et al., 1981) and detected by fluorescence (excitation 398 nm, emission 620 nm; Shimadzu fluorescence detector, model RF-530). Recovery for each porphyrin using this method was (%): URO, 67; heptacarboxyl, 74; hexacarboxyl, 77; pentacarboxyl, 76; copro, 79; and meso, 73 , based on results with a standard mixture (Porphyrin Products, Logan, UT, U.S.A.) added to cells and medium before extraction.
Toxicity of chemicals in hepatocyte cultures
Concentrations of chemicals were regarded as toxic if they decreased the accumulation of porphyrins induced by the combination of 0.14 mM-propylisopropylacetamide and 30 IM-desferrioxamine (Granick et al., 1975 ).
Chemicals to be tested for toxic effects were added 1 h before the inducing chemicals, and accumulated porphyrins due to the induced ALA synthase were measured after 7 h further incubation. We have found this method to be more sensitive for detection of toxicity than microscopic examination, Trypan Blue uptake or release of lactate dehydrogenase. H.p.l.c. of TCB and HCB Purity of the radioactive TCB and HCB was determined by h.p.l.c. using a 10 Is C-18 Radial Pak column and an isocratic liquid phase of methanol/water (9: 1, v/v) and a flow rate of 1 ml/min. Both compounds were eluted as single peaks. Fractions (1 ml) were collected, added to 10 ml of scintillation fluid (ACS; Amersham/Searle, Des Plaines, IL, U.S.A.), and radioactivity was determined in a Searle-Analytic Mark III scintillation spectrometer. Metabolism of these compounds by the cell cultures to water-soluble products was determined by a single extraction of the cells plus medium with 2 vol. ofdichloromethane. The radioactivity in both layers was determined as described above. The remaining organic layer was evaporated under N2 with heating (40°C) and a portion was injected on to the C-18 column. The eluate from this column was collected (1 ml fractions) and radioactivity determined. ALA synthase Activity in intact cells was measured as described previously (Sinclair & Granick, 1977 acetc,ne/HCI extrac-t was mixed with 5 ml ofdiethyl ether in a glass scintillation vial and washed twice with 2 ml of 2 M-HC1 to remove porphyrins and ALA. The diethyl ether was evaporated at 37°C and the haem dissolved in 10 ml of ACS for determination of radioactivity.
RESULTS
Reversal of URO accumulation by piperonyl butoxide as detected by porphyrin composition Previously (Sinclair et al., 1984a) we demonstrated that URO accumulation in intact cultured hepatocytes caused by halogenated biphenyls such as TCB could be detected by changes in the composition of porphyrins generated from added ALA. Cells treated with ALA alone accumulated predominantly PROTO, whereas cells treated with both ALA and TCB accumulated mainly URO and heptacarboxyporphyrins. We also showed that if inhibitors of cytochrome P-450 isoenzymes such as piperonyl butoxide were added before TCB, URO accumulation was prevented. Fig. 1 shows that piperonyl butoxide can also reverse the URO accumulation. Cells treated first with TCB or PBB and then with ALA accumulated URO. After piperonyl butoxide was added to these cultures, URO accumulation stopped and PROTO accumulation was restored almost to the control rate. In the absence of piperonyl butoxide, no PROTO was detected and URO accumulation continued. In the absence of any other treatment, piperonyl butoxide did not induce accumulation of porphyrin and hence had no effect alone. Values for coproporphyrin are not shown, since concentrations of this porphyrin varied minimally with the different treatments. In a similar experiment, SKF-525A, an inhibitor of the major phenobarbitalinduced P-450 isoenzyme (Testa & Jenner, 1981) , had no effect on the porphyrins accumulating from ALA in TCB-treated cells (results not shown). This finding confirms the previous implication of an essential role for MC-inducible isoenzymes in the URO accumulation
caused by halogenated biphenyls (Sinclair et al., 1984a) . These experiments suggest that URO accumulated in the cells as the porphyrin and not the porphyrinogen, since uroporphyrinogen would have been further metabolized by uroporphyrinogen decarboxylase, whereas Fig. 1 indicates URO levels in the cells treated with either polyhalogenated biphenyl plus piperonyl butoxide remained constant over the indicated time period. Previous work has shown URO remains in the cells (Granick et al., 1975; Kawanishi et al., 1983; Sinclair et al., 1983) possibly in lysosomes (Sandberg & Romslo, 1982) . Fig. 2 shows the amount of piperonyl butoxide required to reverse the URO accumulation caused by TCB. These doses of piperonyl butoxide were non-toxic by the criterion of induced porphyrin accumulation used in the present paper (see the Materials and methods section). Concentrations of piperonyl butoxide greater than 45/UM were not soluble in the culture medium. Restoration of TCB-inhibited haem synthesis by piperonyl butoxide of ALA synthase are induced (de Verneuil et al., 1983a) . Also, rats treated with hexachlorobenzene and phenobarbital have highly induced levels of hepatic ALA synthase (Blekkenhorst et al., 1980; Wainstock de Calmanovici et al., 1984) . If piperonyl butoxide restored haem synthesis in the chick liver cultures as well as preventingURO accumulation, then addition ofpiperonyl butoxide should lead to a decrease in ALA synthase activity by restoring the regulatory haem pool. Table 2 shows the results of an experiment in which ALA synthase activity was synergistically induced by combining PIA, a phenobarbital-like inducer in this sysem (Sinclair et al., 1981) (3.8, 4 .2) 9.1 (9.1, 9.1) 11. 8 (11.6, 11.9) ALA synthase by haem [for reviews, see Bonkovsky (1982) non-specific inhibition of ALA synthase by piperonyl butoxide. The cycloheximide treatments (Table 2 , lines 3 and 8) showed that, without continual induced protein synthesis, ALA synthase activity rapidly fell, consistent with the known short half-life of the enzyme (Ades et al., 1983) . Piperonyl butoxide also reversed URO accumulation caused by other compounds Table 3 shows that piperonyl butoxide was also effective in reversing the URO accumulation caused by TCB and other halogenated compounds, including mixtures of polyhalogenated biphenyls (Aroclor, Firemaster), 3,4,5,3',4',5'-hexabromobiphenyl or lindane (yhexachlorocyclohexane). This was indicated by resumption of PROTO accumulation and prevention of further accumulation of URO. Table 4 shows that piperonyl butoxide also reversed URO accumulation caused by treatment of cells with either PIA or phenobarbital (de Verneuil et al., 1983a; Marks et al., 1983) . The recently reported URO accumulations caused by the organophosphorus compound parathion (Nichol & Angel, 1984) and by the Ca2+-channel-blocking drugs nifedipine and verapamil (Schoenfeld et al., 1985) , were also reversible by piperonyl butoxide (results not shown). SKF-525A, the selective inhibitor of the major phenobarbitalinduced isoenzyme of cytochrome P-450, reversed the URO accumulation caused by PIA and phenobarbital, but not that caused by TCB. Further characteristics of the reversal of URO accumulation by piperonyl butoxide Even after 44 h ofTCB pretreatment followed by ALA, piperonyl butoxide almost completely restored PROTO synthesis. When cells were incubated for 19 h with 68 #M-TCB (the limit of solubility) as used by Swain   Table 3 . Reversal by piperonyl butoxide of URO accumulation caused by other compounds Cells in 3.5 cm dishes were treated with the chemicals indicated for 18 h then were either harvested or treated with 30 ,uM-piperonyl butoxide (PipB). After 1 h, ALA (0.15 mM) was added for 6 h further incubation. Porphyrin composition was determined as described in the Materials and methods section. Results are means of two determinations whose values varied less than 5%.
, 'Not done'. Abbreviation: HBB, 3,4,5,3',4',5'-hexabromobiphenyl. (1983) and then treated with ALA and piperonyl butoxide, URO accumulation was stopped and PROTO synthesis restored. In other experiments, the presence or absence of insulin did not affect the results. The ability of piperonyl butoxide to prevent or reverse URO accumulation caused by 3.4 #M-TCB was lost after 17.5 h. However, a second addition ofpiperonyl butoxide to such cells at 17.5 h again reversed URO accumulation, possibly indicating that the loss of effect of piperonyl butoxide after 17.5 h was due to metabolism of piperonyl butoxide itself. This was not investigated further. Reversal of URO accumulation of piperonyl butoxide is independent of protein synthesis Table 5 shows that addition of cycloheximide with piperonyl butoxide did not prevent the reversal of URO accumulation. The effectiveness of cycloheximide as an inhibitor of protein synthesis was shown by its inhibition of induced porphyrin accumulation (see legend to Table 5 ). Cycloheximide at this concentration decreases incorporation of labelled leucine into protein by 85% (J. Sinclair et al., 1984) . In other experiments, addition of cycloheximide 1 h before adding piperonyl butoxide also did not affect the reversal by piperonyl butoxide of URO accumulation.
Reversal of URO accumulation by analogues of piperonyl butoxide
Two structural analogues of piperonyl butoxide, safrole and isosafrole, were also effective at reversing URO accumulation, although their potency and efficacy were lower. For example, 0.2 mM-isosafrole was about as effective as 0.03 mM-piperonyl butoxide. Both safrole and isosafrole were tested (up to concentrations of 0.6 mM); neither was found to be toxic to porphyrin induction (measured as described in the Materials and methods section). The parent ring compound, methylenedioxybenzene, up to I mm, was ineffective at reversing the URO accumulation, as was 0.8 mM-n-butyldioxalane, an analogue to the oxygen-containing ring of piperonyl butoxide (results not shown). 
Reversal of URO accumulation by ellipticine
Previously we found that only inhibitors of MCinducible P-450 isoenzymes would prevent URO accumulation by TCB (Sinclair et al., 1984a) . Ellipticine, the specific inhibitor of MC-inducible cytochrome P-450 (Lesca et al., 1979) , reversed URO accumulation caused by TCB as seen by accumulation of coproporphyrin and PROTO (Fig. 3) . In this case, h.p.l.c. analysis of porphyrins was required to demonstrate the recovery of PROTO synthesis, because ellipticine has a fluorescence emission spectrum similar to PROTO, a fact that made the spectrofluorometric assay for porphyrins unusable.
Ellipticine, like piperonyl butoxide, caused a decrease in ALA synthase activity after treatment with PIA and TCB in experiments analogous to those shown in Table 2 (results not shown).
Reversal of URO accumulation by acetylaminofluorene Previously we reported that 2-acetylaminofluorene is rapidly metabolized by chick liver culture and that piperonyl butoxide, ellipticine and SKF-525A inhibit this metabolism, depending on the P-450 isoenzymes present in the cells (Sinclair et al., 1984a) . Marks (1985) ]. (Fig. 1) . Compounds such as ellipticine, which also bind to and inhibit the activity of the isoenzyme of cytochrome P-450 induced by methylcholanthrene, were also effective (Fig. 3) . These results conflict with the generally held hypotheses that the mechanism ofthe URO accumulation caused by polyhalogenated aromatic compounds is mediated via metabolites that covalently bind to uroporphyrinogen decarboxylase (de Verneuil et al., 1983a; Swain et al., 1983; Wainstock de Calmanovici et al., 1984; Cantoni et al., 1984a; Sinclair et al., 1984a; Marks, 1985) or that oxidize some essential thiol group of this enzyme (Debets et al., 198 lb) .
The action of piperonyl butoxide in reversing URO accumulation in the intact cells was confirmed by two independent assays of haem synthesis: (i) the conversion of [14C]ALA into haem (Table 1) , and (ii) the decrease of ALA synthase activity induced by combination of PIA and TCB (Table 2) . These results taken together strongly indicate that, in the intact cells, conversion of uroporphyrinogen into coproporphyrinogen and hence haem was restored by the action of piperonyl butoxide.
The reversal of URO accumulation by piperonyl butoxide was achievable under all the conditions by which we and others have reported URO accumulation in the intact chick-embryo liver cells. These include treatment (i) with halogenated compounds for 2 days, (ii) with high TCB concentrations (Swain et al., 1983) , (iii) with a variety of halogenated compounds (Table 3) , (iv) with PIA and phenobarbital (Table 4) , (v) with parathion, an organophosphorous compound that causes URO accumulation (Nichol & Angel, 1984) and (vi) with the Ca2+-channel-blocking agents nifedipin and verpamil (Schoenfeld et al., 1985) . Recently we found URO accumulation caused by TCDD (Sinclair & Granick, 1974; de Verneuil et al., 1983a) was also reversible by piperonyl butoxide (Lambrecht et al., 1986) . We have shown that accumulation of URO from exogenous ALA is detectable by treatment of chick hepatocyte cultures with PBB at concentrations lower than those required to cause detectable decreases in uroporphyrinogen decarboxylase activity as assayed by a conventional assay in vitro (Sinclair et al., 1983) . The present results show that piperonyl butoxide restored normal haem synthesis at all concentrations of halogenated biphenyl studied.
Some comments on the validity of assays in the intact cells are appropriate. In these and previous studies (Sinclair et al., 1983 (Sinclair et al., , 1984a , porphyrin composition was determined by the fluorimetric assay of Grandchamp Vol. 237 et al. (1980) . By using reverse-phase h.p.l.c. we have now further validated that fluorimetric assay (Fig. 3) Previously (Sinclair et al., 1984a) we showed that the induction of the P-450 isoenzyme induced by methylcholanthrene is a prerequisite for URO accumulation caused by the halogenated biphenyls. Here we have demonstrated that either inhibitors of cytochrome P-450 (piperonyl butoxide, some methylenedioxybenzene -analogues and ellipticine) or a highly metabolized substrate of cytochrome P-450 (acetylaminofluorene) can reverse URO accumulation ( Figs. 1 and 3 ; Table 6 ). One explanation for the action of these compounds is that they prevent formation of an inhibitor of uroporphyrinogen decarboxylase derived from the halogenated biphenyl. However, a problem with this hypothesis is that, although one compound that caused URO accumulation, TCB, was measurably metabolized in the culture, another more halogenated biphenyl, HCB, was scarcely metabolized at all (Table 7) . Indeed, h.p.l.c. of the organic phase indicated no other HCB-derived compound except HCB itself. Therefore, if the inhibitor were a metabolite of HCB, it would have to be extremely potent and specific, since we calculate that, on a molar basis, the amount of water-soluble metabolite of HCB could be no greater than the amount of uroporphyrinogen decarboxylase in the cells. The calculation is based on published values for the Mr and the specific activity of human uroporphyrinogen decarboxylase (de Verneuil et al., 1983b; Elder et al., 1983) with pentacarboxyl-porphyrinogen III as substrate. Assuming that the specific activity and Mr of human and chick enzymes are similar, we calculate that 1 mg of chick hepatocyte-cell protein contains 1-4 pmol of uroporphyrinogen decarboxylase.
Consistent with data of other workers (de Verneuil et al., 1983a; Marks et al., 1983) , we showed that URO accumulation followed treatment of the cells with inducers of other isoenzymes of cytochrome P-450, PIA or phenobarbital (Table 4) . de Verneuil et al. (1983a) suggested a role for the phenobarbital-induced P-450 isoenzyme in the mechanism of URO accumulation caused by phenobarbital. This isoenzyme may also be involved in the URO accumulation caused by aliphatic alcohols in this cell-culture system . Participation of this P-450 isoenzyme is supported by our finding that SKF-525A reversed the URO accumulation caused by phenobarbital (Table 4) . However, SKF-525A was not effective against the URO accumulation caused by TCB (Table 4) (Debets et al., 1980) , indicating that, in the URO accumulation caused by the biphenyls, another isoenzyme of cytochrome P-450 must be involved (Sinclair et al., 1984a) .
Since cycloheximide failed to affect the ability of piperonyl butoxide to reverse URO accumulation (Table  5 ) and since the reversal was so rapid (Fig. 1) , it seems that synthesis de novo ofuroporphyrinogen decarboxylase was not involved in the mechanism of the reversal. It is not yet known whether piperonyl butoxide administered to animals will reverse the hepatic accumulation and excretion of URO caused by halogenated aromatic compounds. In rodents, it may be difficult to maintain effective concentrations of piperonyl butoxide, since it is known that the effects of piperonyl butoxide to inhibit drug metabolism are lost in mice within 12 h (Skrinjaric-Spoljar et al., 1971) . Even in culture, the effect of piperonyl butoxide did not persist beyond 18 h. In intact rodents the accumulation of URO is over a longer period (weeks to months) (Elder et al., 1976; Jones & Sweeney, 1980 ) than in our culture experiments (maximum 4 days) in which reversibility by piperonyl butoxide was maintained.
Conclusions on mechanism of URO accumulation
The present results show that, in the intact chick hepatocyte, accumulation of URO caused by some halogenated biphenyls is rapidly reversed by compounds that are known to bind to, and inhibit, the P-448 isoenzyme of cytochrome P-450. These results conflict with virtually all the current proposals to explain the mechanism of URO accumulation. In particular, these data seem to exclude irreversible covalent binding to uroporphyrinogen decarboxylase by an inhibitory metabolite of the biphenyl as the mechanism for URO accumulation. Direct inhibition of the enzyme by the biphenyls has been proposed (Kawinishi et al., 1983) , and this is not excluded by our data. The presence of stable inhibitors of uroporphyrinogen decarboxylase in livers from hexachlorobenzene-treated rats (Rios de Molina et al., 1980) and TCDD-treated mice (Cantoni et al., 1984b) have also been reported. However, as previously discussed (Sinclair et al., 1984a) , we and others have produced evidence that a cytochrome P-450 isoenzyme plays an essential role in the uroporphyria caused by halogenated biphenyls. Since a direct role of the biphenyl metabolites is unlikely, we suggest that the role of the P-450 isoenzymes is to bind the biphenyls and to generate a form of activated oxygen. Piperonyl butoxide and acetylaminofluorene would prevent binding of the biphenyl and the oxygen species would then decay or be degraded by cellular protective enzymes. The activated oxygen species may reversibly attack uroporphyrinogen decarboxylase itself. We consider it more likely that the oxygen species may oxidize the substrates (uroporphyrinogen and heptacarboxyporphyrinogen) to porphyrins that are themselves not substrates of uroporphyrinogen decarboxylase. A central role of the oxidation of porphyrinogen substrates in the development ofporphyria cutanea tarda was suggested previously (Heikel et al., 1958) and has been recently revived (Pimstone, 1982; Mukerji et al., 1984) . There is evidence that microsomal cytochrome P-450s produce H202 owing to uncoupling of the mono-oxygenase reaction (Kuthan et al., 1978; Kuthan & Ullrich, 1982) , particularly when nonmetabolizable substrates are bound. Ferioli et al. (1984) have also recently proposed this possibility. Isolated rat hepatocytes generate H202 during metabolism of hexobarbital (Eklow et al., 1984) . Evidence in favour of this oxidant hypothesis to explain the action of TCB and PBB in the chick culture is that URO, rather than the reduced porphyrinogen, accumulated in cells (Fig. 1) . Recent experiments in our laboratory (P. Sinclair, unpublished work) show that uroporphyrinogen I is oxidized in the presence of NADPH and TCB by microsomal cytochrome P-450 from MC-treated chick embryos. Further work is needed to examine the oxidation hypothesis and to determine whether measurements of activities of uroporphyrinogen decarboxylase in cell homogenates correlate with the observations with intact living cells described here. 
